Skip to main content
Clinical Trials/NCT02936986
NCT02936986
Completed
Not Applicable

Endoscopic Ultrasound-guided Needle-based Confocal Laser Endomicroscopy for Diagnosis of Gastric Subepithelial Tumors

Shandong University1 site in 1 country94 target enrollmentMay 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gastric Subepithelial Tumors
Sponsor
Shandong University
Enrollment
94
Locations
1
Primary Endpoint
The nCLE interpretation criteria for the characterization of gastric subepithelial tumors with histopathological correlation
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The differential diagnosis of gastric subepithelial tumors by endoscopic ultrasound is currently suboptimal. Needle-based confocal laser endomicroscopy (nCLE) is a novel endoscopic technique, which is compatible with the 19-gauge FNA needle. Under endoscopic ultrasonography (EUS) guidance, nCLE enables real-time in vivo imaging of lesion tissues at cellular and subcellular levels. This study aimed to describe nCLE interpretation criteria for the characterization of gastric subepithelial tumors, with histopathological correlation, and to perform the validation of these criteria.

Registry
clinicaltrials.gov
Start Date
May 2016
End Date
April 2018
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Shandong University
Responsible Party
Principal Investigator
Principal Investigator

Yanqing Li

Official Title: Vice president of Qilu Hospital

Shandong University

Eligibility Criteria

Inclusion Criteria

  • patients aged from 18 to 75 years, with gastric subepithelial tumors ≥ 2 cm

Exclusion Criteria

  • Previous EUS-FNA performed within the past 3 months, and usual contraindications to EUS-FNA, such as serous cardiopulmonary diseases, severe coagulopathy dysfunction, impaired kidney function
  • Extramural structures, vascular lesions or cystic masses were visible by EUS
  • Pregnancy or breastfeeding
  • Known allergy to fluorescein sodium
  • Inability to provide informed consent
  • Validation study
  • Inclusion Criteria:
  • patients aged from 18 to 75 years, with gastric subepithelial tumors ≥ 1 cm
  • Exclusion Criteria:
  • Previous EUS-FNA performed within the past 3 months, and usual contraindications to EUS-FNA, such as serous cardiopulmonary diseases, severe coagulopathy dysfunction, impaired kidney function

Outcomes

Primary Outcomes

The nCLE interpretation criteria for the characterization of gastric subepithelial tumors with histopathological correlation

Time Frame: 24 months

The feasibility, safety and diagnostic yield of nCLE for gastric subepithelial tumors

Time Frame: 24 months

Study Sites (1)

Loading locations...

Similar Trials